Phase 1 study of efatutazone, a novel oral peroxisome...

Investigational New Drugs 2014 / 06 Vol. 32; Iss. 3

Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer

Komatsu, Yoshito, Yoshino, Takayuki, Yamazaki, Kentaro, Yuki, Satoshi, Machida, Nozomu, Sasaki, Takahide, Hyodo, Ichinosuke, Yachi, Yutaka, Onuma, Hiroshi, Ohtsu, Atsushi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-013-0056-3
Date:
June, 2014
File:
PDF, 279 KB
english, 2014
Conversion to is in progress
Conversion to is failed